• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

    8/10/22 3:52:26 AM ET
    $AEL
    $AEO
    $AERC
    $AHCO
    Life Insurance
    Finance
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $AEL alert in real time by email

    Gainers

    • AeroClean Technologies, Inc. (NASDAQ:AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
    • BBQ Holdings, Inc. (NASDAQ:BBQ) jumped 46.6% to close at $17.18 after the company announced MTY Food Group entered into a definitive merger agreement to acquire all of the outstanding shares of the company for $17.25 per share.
    • Verona Pharma plc (NASDAQ:VRNA) shares climbed 44.3% to close at $10.03 on Tuesday after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
    • FaZe Holdings Inc. (NASDAQ:FAZE) gained 42.4% to settle at $20.08 on continued volatility following the company's recent completion of its SPAC merger.
    • Cuentas Inc. (NASDAQ:CUEN) gained 35.2% to close at $0.8543.
    • Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares climbed 33.3% to settle at $7.00. Mersana Therapeutics announced a global collaboration that provides GSK plc an exclusive option to co-develop and commercialize XMT-2056.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) gained 32.1% to settle at $5.18. Avalo Therapeutics has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER).
    • Akanda Corp. (NASDAQ:AKAN) climbed 30.2% to close at $1.25. Akanda will supply Cansativa with premium indoor cannabis flower grown at its Sintra facility in Portugal.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) jumped 29.2% to close at $4.69 after reporting a profit for the second quarter.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) jumped 25.9% to close at $0.9212 after the company announced its subsidiary REIT Ecological Technology has won the bid for the Longxi County Comprehensive Land Management and Logistics Zone EOD Project.
    • DPCM Capital, Inc. (NYSE:QBTS) gained 24% to settle at $12.40. D-Wave Quantum is expected to release its financial results for the second quarter on Tuesday, August 16, 2022 after market close.
    • PubMatic, Inc. (NASDAQ:PUBM) climbed 23.8% to close at $21.98 after reporting strong quarterly results.
    • RenovoRx, Inc. (NASDAQ:RNXT) gained 23.6% to settle at $2.62.
    • Tuesday Morning Corporation (NASDAQ:TUEM) gained 22.2% to close at $0.44 after gaining around 68% on Monday.
    • Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) rose 21.5% to settle at $8.86.
    • Nielsen Holdings plc (NYSE:NLSN) surged 21.3% to close at $27.54. Nielsen postponed court and special meetings of shareholders to permit finalization of preliminary agreement between consortium and The WindAcre Partnership LLC.
    • Edgio, Inc. (NASDAQ:EGIO) gained 20.6% to settle at $3.39 after the company reported better-than-expected Q2 results.
    • RumbleON, Inc. (NASDAQ:RMBL) jumped 19.4% to close at $24.41 after the company reported better-than-expected Q2 results.
    • IDW Media Holdings, Inc. (NYSE:IDW) surged 18.3% to settle at $1.62.
    • Performance Shipping Inc. (NASDAQ:PSHG) rose 17.8% to settle at $0.41.
    • Ambac Financial Group, Inc. (NYSE:AMBC) gained 17.4% to close at $13.09 following upbeat Q2 results.
    • ShockWave Medical, Inc. (NASDAQ:SWAV) climbed 17.1% to settle at $259.61 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 sales guidance above analyst estimates.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 16.4% to settle at $0.5333
    • Ontrak, Inc. (NASDAQ:OTRK) shares climbed 16.1% to close at $0.79. Ontrak recently reported closing of registered direct offering for aggregate gross proceeds of $4.0 million.
    • Tricida, Inc. (NASDAQ:TCDA) surged 15.5% to close at $12.47 following strong quarterly earnings.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) gained 15.1% to close at $4.11 after the company posted upbeat quarterly sales and raised FY22 net product sales guidance.
    • AlloVir, Inc. (NASDAQ:ALVR) jumped 14% to close at $8.00. The company recently released quarterly results.
    • American Equity Investment Life Holding Company (NYSE:AEL) jumped 13% to close at $40.95 after the company reported better-than-expected Q2 EPS and sales results.
    • Lemonade, Inc. (NYSE:LMND) shares rose 12.2% to close at $28.16 after the company reported better-than-expected Q2 results and issued sales guidance above estimates.
    • Qualys, Inc. (NASDAQ:QLYS) climbed 12% to close at $142.70 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 sales guidance above analyst estimates.
    • PowerSchool Holdings, Inc. (NYSE:PWSC) gained 9.3% to settle at $16.89 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 sales guidance above analyst estimates.
    • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) climbed 8.1% to close at $39.77. Stifel maintained Cerevel Therapeutics with a Buy and raised the price target from $50 to $54.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 8% to settle at $3.93.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) rose 7.7% to close at $8.52 after the company reported better-than-expected Q2 sales results.
    • Viasat, Inc. (NASDAQ:VSAT) gained 7.3% to $37.30 after the company reported Q1 results.
    • Principal Financial Group, Inc. (NYSE:PFG) gained 7.1% to settle at $73.69 after the company reported better-than-expected Q2 adjusted EPS results. Additionally, Morgan Stanley raised its price target from $65 to $68.
    • Enovix Corporation (NASDAQ:ENVX) rose 5.2% to close at $14.41 after declining around 5% on Monday. JP Morgan recently initiated coverage on Enovix with an Overweight rating and announced a price target of $20.
    • News Corporation (NASDAQ:NWSA) gained 5.2% to close at $18.27 after the company reported Q4 EPS results up year over year and better-than-expected sales results.

     

    Losers

    • Magic Empire Global Limited (NASDAQ:MEGL) dipped 89.5% to close at $12.32 on volatility following the company's IPO on Friday.
    • CorMedix Inc. (NASDAQ:CRMD) fell 57.5% to close at $3.20 after the company announced it received a second Complete Response Letter from the FDA stating that the DefenCath NDA cannot be approved until certain deficiencies are resolved to the satisfaction of the FDA.
    • Quanterix Corporation (NASDAQ:QTRX) shares fell 54.8% to close at $7.46 after the company announced Q2 results and provided an update on clinical development programs.
    • Aytu BioPharma, Inc. (NASDAQ:AYTU) shares dipped 51.5% to close at $0.2814 after the company announced the launch of public offering.
    • AMTD Digital Inc. (NYSE:HKD) dropped 47.7% to close at $212.00 on possible profit taking after the stock surged over the last few trading days.
    • Medicenna Therapeutics Corp. (NASDAQ:MDNA) fell 46.6% to close at $0.95 after the company announced the launch of a marketed underwritten public offering of 13,333,334 units priced at $1.50 per unit.
    • Avaya Holdings Corp. (NASDAQ:AVYA) dipped 45.5% to close at $0.6101 after the company issued Q3 EPS and sales guidance below analyst estimates.
    • Vertex Energy, Inc. (NASDAQ:VTNR) declined 44.2% to settle at $7.80 after the company reported worse-than-expected Q2 EPS.
    • SKYX Platforms Corp. (NASDAQ:SKYX) dropped 41.4% to close at $3.60. SKYX achieved historic U.S. standardization approval vote – a major milestone towards mandatory status for safety of consumers and professionals.
    • Endo International plc (NASDAQ:ENDP) declined 39.7% to settle at $0.4030 after the company reported a 20% year-over-year drop in Q2 revenues and said it remains in negotiations with creditors. The company expects negotiations to result in a pre-arranged filing under Chapter 11 of the U.S. Bankruptcy Code.
    • Senmiao Technology Limited (NASDAQ:AIHS) dipped 36.8% to close at $1.20 after the company reported ride-hailing platform operating metrics for July.
    • Vroom, Inc. (NASDAQ:VRM) dropped 35.4% to close at $1.59 after the company reported worse-than-expected Q2 sales.
    • DermTech, Inc. (NASDAQ:DMTK) declined 34.1% to close at $5.56 after the company reported worse-than-expected Q2 sales results.
    • Turtle Beach Corporation (NASDAQ:HEAR) shares fell 31.8% to close at $9.54 after reporting downbeat second quarter financial results and announced an update to a strategic review.
    • Novavax, Inc. (NASDAQ:NVAX) dipped 29.6% to close at $40.28 after the company reported second-quarter revenue decline of 37.6% year-over-year to $185.9 million. The company also lowered its sales forecast for the year.
    • Oportun Financial Corporation (NASDAQ:OPRT) fell 28.5% to close at $7.70 following Q2 results.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) dropped 28.4% to close at $3.63.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 28% to settle at $1.72.
    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) shares declined 27.4% to close at $0.6520 on Tuesday. eFFECTOR Therapeutics appointed Douglas Warner, M.D., as chief medical officer.
    • Eargo, Inc. (NASDAQ:EAR) dipped 27% to settle at $1.00 after the company posted a wider Q2 loss.
    • Quanergy Systems, Inc. (NYSE:QNGY) fell 26.6% to close at $0.3302.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) fell 26.5% to close at $5.79 after gaining 65% on Monday.
    • SOS Limited (NYSE:SOS) fell 26.3% to close at $7.30.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) dropped 26.2% to close at $2.42 after the company provided an update of its preliminary Phase 1 dose-escalation data for XTX101. The company also reported Q2 financial results.
    • CarGurus, Inc. (NASDAQ:CARG) fell 25.5% to close at $19.16 after the company issued weak forecast for the third quarter.
    • Superior Group of Companies, Inc. (NASDAQ:SGC) declined 25.4% to end at $13.93 following downbeat quarterly earnings.
    • Root, Inc. (NASDAQ:ROOT) fell 24.8% to close at $1.03 after the company reported Q2 results and announced a 1-for-18 reverse stock split.
    • American Vanguard Corporation (NYSE:AVD) declined 24.3% to close at $18.29 after the company reported worse-than-expected Q2 sales results.
    • TaskUs, Inc. (NASDAQ:TASK) dropped 24.3% to close at $17.73 after the company issued FY22 sales guidance below estimates.
    • Workhorse Group Inc. (NASDAQ:WKHS) fell 24.2% to settle at $3.39 after the company reported Q2 earnings results and said it now expects to manufacture and sell between 150 to 250 vehicles and generate between $15 million to $25 million in revenue for calendar year 2022.
    • Minerva Neurosciences, Inc. (NASDAQ:NERV) dropped 23.9% to close at $3.60 after the company reported Q2 earnings results.
    • Artelo Biosciences, Inc. (NASDAQ:ARTL) dipped 23.6% to close at $0.2701 after the company reported Q3 EPS results were lower year over year. Also, the company announced a 15-for-1 reverse stock split.
    • Westport Fuel Systems Inc. (NASDAQ:WPRT) declined 22.6% to close at $1.20 after reporting a Q2 loss.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 22.1% to close at $0.4050.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) dropped 22% to close at $0.6240.
    • LivePerson, Inc. (NASDAQ:LPSN) fell 21.8% to close at $12.95 after the company reported worse-than-expected Q2 EPS and sales results. The company also lowered FY22 sales guidance below analyst estimates and issued Q3 sales guidance below estimates.
    • National CineMedia, Inc. (NASDAQ:NCMI) dropped 21.6% to close at $1.3950 following Q2 results.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) fell 21.4% to close at $1.40. Iveda Solutions announced a $5 million private placement.
    • AMTD IDEA Group (NYSE:AMTD) fell 20.8% to settle at $2.36 amid continued profit takin.
    • Allbirds, Inc. (NASDAQ:BIRD) fell 19.2% to close at $4.58 after the company issued Q3 and FY22 sales guidance below estimates.
    • Clover Health Investments, Corp. (NASDAQ:CLOV) fell 17.9% to close at $2.79 after the company reported financial results and reaffirmed full-year guidance.
    • Standard BioTools Inc. (NYSE:LAB) declined 17.7% to settle at $1.68 following Q2 results.
    • Wayfair Inc. (NYSE:W) dropped 17% to close at $59.61.
    • Shift Technologies, Inc. (NASDAQ:SFT) fell 16.3% to close at $1.28.
    • The Beauty Health Company (NASDAQ:SKIN) dipped 16.2% to settle at $12.80 after the company reported Q2 earnings results.
    • Freshpet, Inc. (NASDAQ:FRPT) fell 15.1% to close at $47.84 after the company reported worse-than-expected Q2 EPS and sales results.
    • 3D Systems Corporation (NYSE:DDD) shares fell 15% to settle at $11.26 after the company reported a loss for its second quarter and lowered its FY22 sales guidance.
    • Trex Company, Inc. (NYSE:TREX) fell 15% to close at $54.28 following Q2 results.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 14.2% to close at $9.79. Baird downgraded Bed Bath & Beyond from Neutral to Underperform and announced a $4 price target.
    • Twist Bioscience Corporation (NASDAQ:TWST) dropped 14.2% to settle at $48.53. Twist Bioscience recently reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance above analyst estimates.
    • Aterian, Inc. (NASDAQ:ATER) fell 14.1% to close at $2.56 as the company reported second-quarter financial results.
    • AdaptHealth Corp. (NASDAQ:AHCO) dipped 13.5% to settle at $22.24 after the company reported worse-than-expected Q2 EPS results.
    • bluebird bio, Inc. (NASDAQ:BLUE) fell 13.3% to close at $5.50 after jumping 13% on Monday.
    • Helios Technologies, Inc. (NASDAQ:HLIO) fell 13% to close at $61.15 after the company reported Q2 earnings results.
    • Onto Innovation Inc. (NYSE:ONTO) declined 12.1% to close at $74.81 after Q2 results.
    • Upstart Holdings, Inc (NASDAQ:UPST) fell 11.8% to close at $28.45 after the company reported Q2 results and issued Q3 sales guidance below estimates.
    • Signet Jewelers Limited (NYSE:SIG) declined 11.7% to close at $59.75 after the company cut FY23 sales guidance below analyst estimates.
    • ICU Medical, Inc. (NASDAQ:ICUI) fell 11.6% to close at $166.31 after the company reported worse-than-expected Q2 EPS and sales results.
    • Synaptics Incorporated (NASDAQ:SYNA) dropped 11.3% to close at $128.78.
    • ironSource Ltd. (NYSE:IS) fell 11.2% to settle at $4.20.
    • Nikola Corporation (NASDAQ:NKLA) dropped 10.6% to close at $6.96 amid profit taking in clean energy vehicles stocks as well as broader risk-off sentiment.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 10.6% to close at $87.68.
    • Helbiz, Inc. (NASDAQ:HLBZ) fell 10.6% to close at $1.44 after jumping 115% on Monday.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) dipped 10.5% to close at $12.10 after the company reported worse-than-expected Q2 results and issued Q3 guidance below estimates.
    • Doximity, Inc. (NYSE:DOCS) fell 10.2% to settle at $36.49. Doximity recently lowered FY23 sales guidance.
    • Guardant Health, Inc. (NASDAQ:GH) dipped 10.2% to close at $48.96.
    • American Eagle Outfitters, Inc. (NYSE:AEO) fell 9% to close at $11.49.
    • BIMI International Medical Inc. (NASDAQ:BIMI) shares fell 8.7% to close at $0.56. Fnu Oudom reported a stake of 44% in the company in a 13D filing.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) fell 6.9% to close at $0.1210. T2 Biosystems said it will explore potential to develop rapid molecular diagnostic test for monkeypox virus.
    • 23andMe Holding Co (NASDAQ:ME) fell 6.3% to close at $3.73 after the company reported worse-than-expected Q2 EPS results.
    • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) fell 5.4% to close at $1.22. TOMI Environmental Solutions shares jumped over 29% on Monday after the company highlighted its SteraMist as a disinfectant against the Monkeypox virus.
    • Ralph Lauren Corporation (NYSE:RL) fell 4.3% to close at $96.77 following Q1 results.
    • Tesla, Inc. (NASDAQ:TSLA) fell 2.4% to close at $850.00.
    Get the next $AEL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEL
    $AEO
    $AERC
    $AHCO

    CompanyDatePrice TargetRatingAnalyst
    Wayfair Inc.
    $W
    2/20/2026$114.00 → $105.00Overweight
    Analyst
    Guardant Health Inc.
    $GH
    2/20/2026$125.00 → $135.00Buy
    Canaccord Genuity
    Guardant Health Inc.
    $GH
    2/17/2026$120.00Outperform
    Robert W. Baird
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    Onto Innovation Inc.
    $ONTO
    2/17/2026$275.00Neutral → Overweight
    Cantor Fitzgerald
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Upstart Holdings Inc.
    $UPST
    2/13/2026$35.00Sell → Neutral
    Goldman
    More analyst ratings

    $AEL
    $AEO
    $AERC
    $AHCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Agah Ramtin bought $9,975 worth of shares (10,000 units at $1.00), increasing direct ownership by 1% to 798,460 units (SEC Form 4)

    4 - RenovoRx, Inc. (0001574094) (Issuer)

    1/22/26 7:00:18 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $AEL
    $AEO
    $AERC
    $AHCO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AEL
    $AEO
    $AERC
    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Wayfair with a new price target

    Analyst reiterated coverage of Wayfair with a rating of Overweight and set a new price target of $105.00 from $114.00 previously

    2/20/26 10:42:01 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Canaccord Genuity reiterated coverage on Guardant Health with a new price target

    Canaccord Genuity reiterated coverage of Guardant Health with a rating of Buy and set a new price target of $135.00 from $125.00 previously

    2/20/26 8:00:16 AM ET
    $GH
    Medical Specialities
    Health Care

    Robert W. Baird initiated coverage on Guardant Health with a new price target

    Robert W. Baird initiated coverage of Guardant Health with a rating of Outperform and set a new price target of $120.00

    2/17/26 8:18:22 AM ET
    $GH
    Medical Specialities
    Health Care

    $AEL
    $AEO
    $AERC
    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Talluri Rajendra K covered exercise/tax liability with 17,650 shares, decreasing direct ownership by 0.79% to 2,202,787 units (SEC Form 4)

    4 - Enovix Corp (0001828318) (Issuer)

    2/20/26 6:42:04 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Chief Executive Officer Timm Alexander E. was granted 122,395 shares and covered exercise/tax liability with 14,470 shares, increasing direct ownership by 71% to 259,337 units (SEC Form 4)

    4 - Root, Inc. (0001788882) (Issuer)

    2/20/26 4:10:28 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    President and CTO Bonakdarpour Mahtiyar was granted 107,835 shares and covered exercise/tax liability with 12,191 shares, increasing direct ownership by 36% to 361,198 units (SEC Form 4)

    4 - Root, Inc. (0001788882) (Issuer)

    2/20/26 4:09:49 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    $AEL
    $AEO
    $AERC
    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Welcome to Our Open House: Realtor.com® Announces SXSW 2026 Line Up

    The Two-Day "Open House" is THE Central Hub for Real Estate, Housing and Technology, featuring cookbook author and country music entertainer Hannah Dasher, music duo Dorio and more, at Realtor.com®'s East Austin HeadquartersAUSTIN, Texas, Feb. 20, 2026 /PRNewswire/ -- During SXSW 2026, Realtor.com® is turning its Austin headquarters into the ultimate neighborhood hub with the Realtor.com® Open House, a two-day experience designed to meet the festival where it lives: at the intersection of culture, innovation, and real-world impact. On Friday, March 13, the doors open to a relaxed Friday morning café featuring a live performance and recipe tasting with cookbook author and country music entert

    2/20/26 1:39:00 PM ET
    $NWS
    $NWSA
    Newspapers/Magazines
    Consumer Discretionary

    Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

    Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2025 financial results. Quanterix will issue a press release regarding its fourth quarter and full year 2025 financial results prior to the conference call on Monday, March 2, 2026, after the market closes. The press release will be posted on the Quanterix website at http://www.quanterix.com/. To listen to the live conference call, investors can dial (800) 715-9871 or (646) 307-1963 and enter conference ID 79

    2/20/26 8:33:00 AM ET
    $QTRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Upstart Announces Inaugural $200M Upstart Auto Forward-Flow Agreement with Wafra

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced a forward-flow commitment from funds managed by Wafra, a New York-based global alternative investment manager focused on strategic partnerships, real estate and real assets. Wafra has agreed to purchase up to $200 million of assets originated through the Upstart auto finance platform. "We are pleased to partner with Upstart on its inaugural auto finance forward-flow program," said Paul Steinberger, Managing Director at Wafra. "This partnership exemplifies how we work with leaders in the asset-based finance ecosystem on strategies to deliver credit exposures that offer compel

    2/20/26 8:05:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $AEL
    $AEO
    $AERC
    $AHCO
    SEC Filings

    View All

    SEC Form 10-K filed by Qualys Inc.

    10-K - QUALYS, INC. (0001107843) (Filer)

    2/20/26 5:06:20 PM ET
    $QLYS
    Computer Software: Prepackaged Software
    Technology

    ICU Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - ICU MEDICAL INC/DE (0000883984) (Filer)

    2/20/26 4:27:22 PM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Upstart Holdings Inc.

    144 - Upstart Holdings, Inc. (0001647639) (Subject)

    2/20/26 4:06:33 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $AEL
    $AEO
    $AERC
    $AHCO
    Leadership Updates

    Live Leadership Updates

    View All

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Superior Group of Companies to Announce Fourth Quarter and Full Year 2025 Results

    ST. PETERSBURG, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ:SGC) (the "Company") today announced that it will release the results of its operations for the fourth quarter and full year 2025 after the market close on Tuesday, March 3, 2026. Michael Benstock, Chairman and Chief Executive Officer, and Mike Koempel, President and Chief Financial Officer, will host a teleconference at 5:00 pm Eastern Time that day to discuss the Company's results. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/presentations. Interested individuals may also join the t

    2/17/26 4:22:00 PM ET
    $SGC
    Apparel
    Consumer Discretionary

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEL
    $AEO
    $AERC
    $AHCO
    Financials

    Live finance-specific insights

    View All

    Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

    Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2025 financial results. Quanterix will issue a press release regarding its fourth quarter and full year 2025 financial results prior to the conference call on Monday, March 2, 2026, after the market closes. The press release will be posted on the Quanterix website at http://www.quanterix.com/. To listen to the live conference call, investors can dial (800) 715-9871 or (646) 307-1963 and enter conference ID 79

    2/20/26 8:33:00 AM ET
    $QTRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Onto Innovation Reports 2025 Fourth Quarter and Full Year Results

    Onto Innovation Inc. (NYSE:ONTO) ("Onto Innovation," "Onto," or the "Company") today announced financial results for the fourth quarter and full year 2025. Fourth Quarter and Full Year Business and Financial Highlights: Record quarterly revenue of $267 million in the fourth quarter and full year revenue of $1.005 billion. Completed acquisition of key product lines from the materials analysis business of Semilab International. Next generation Dragonfly® shipped to multiple customers with evaluation periods now ongoing. Closed a new volume purchase agreement estimated at over $240 million with a leading high bandwidth memory (HBM) manufacturer for Dragonfly® 2D inspection and 3D

    2/19/26 4:05:00 PM ET
    $ONTO
    Industrial Machinery/Components
    Industrials

    CarGurus Announces Fourth Quarter and Full-Year 2025 Results

    Full-year 2025 revenue from continuing operations grew 14% YoY for the second consecutive year Full-year 2025 GAAP Net Income from continuing operations of $196.7 million, up 53% YoY; Non-GAAP Adjusted EBITDA from continuing operations of $319.0 million, up 25% YoY Repurchased approximately $350 million worth of shares in 2025, and announces new $250.0 million share repurchase program for 2026 BOSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- CarGurus, Inc. (NASDAQ:CARG), the No. 1 visited automotive shopping site in the U.S.1, today announced financial results for the fourth quarter and year ended December 31, 2025. "2025 was a pivotal year for CarGurus as we delivered strong financial perfor

    2/19/26 4:05:00 PM ET
    $CARG
    EDP Services
    Technology

    $AEL
    $AEO
    $AERC
    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:31:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    $AEL
    $AEO
    $AERC
    $AHCO
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care